Chargement en cours...
Denosumab could be a Potential Inhibitor of Valvular Interstitial Cells Calcification in vitro
OBJECTIVE: Denosumab is a fully human monoclonal antibody and novel antiresorptive agent that works by binding receptor activator of nuclear factor kappa-β ligand (RANKL) and inhibiting the signaling cascade that causes osteoclast maturation, activity, and survival. We aimed to elucidate the effect...
Enregistré dans:
| Publié dans: | Int J Cardiovasc Res |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4959558/ https://ncbi.nlm.nih.gov/pubmed/27468412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4172/2324-8602.1000249 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|